Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein

A. Gotoh, K. Miyazawa, K. Ohyashiki, T. Tauchi, H. Boswell, Hal Broxmeyer, K. Toyama

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Focal adhesion kinase (p125(FAK); FAK) is a protein tyrosine kinase that is tyrosine-phosphorylated in response to v-src-mediated transformation cell adhesion, and stimulation with neuropeptides. To elucidate a possible functional relationship between FAK and BCR-ABL oncoprotein detected in Philadelphia chromosome-positive (Ph+) leukemias, we investigated the tyrosine phosphorylation state of FAK in a murine growth factor-dependent cell line and in its stable human bcr-abl cDNA transfectant. In interleukin-3 (IL-3)-dependent NFS/N1.H7 cells, tyrosine phosphorylation of FAK was not detected after stimulation with either IL-3 or Steel factor (SLF), both of which involve Pas-mediated signaling pathways. However, stable gene transfection with p210(bcr-abl) cDNA into H7 cells made these cells growth factor-independent for proliferation and resulted in constitutive tyrosine phosphorylation and kinase activation of FAK. Constitutive phosphorylation and activation of PAK was also observed in all Ph+ leukemia cell lines examined-that is, K562, TS9;22, and YS9;22, which express p210(BCR-ABL), and NALM-21 and YS9;22, which express p185(BCR-ABL). Ph-negative (Ph-) cell lines, such as MO7e and JM, did not show any detectable tyrosine phosphorylation of FAK. FAK phosphorylation in BCR-ABL-expressing cells was inhibited in a dose-dependent manner by cytochalasin D, a reagent that disrupts the intracellular network of actin filaments. However, no suppression of kinase activity or protein expression of BCR-ABL was observed after treatment with cytochalasin D. A physical association between BCR-ABL and FAK was not apparent. These data suggest that BCR-ABL may be involved in the activation of FAK. Moreover, FAK may be distinct from components in Pas-mediated signaling cascades that are activated by stimulation of myeloid cells with various cytokines.

Original languageEnglish (US)
Pages (from-to)1153-1159
Number of pages7
JournalExperimental Hematology
Volume23
Issue number11
StatePublished - 1995
Externally publishedYes

Fingerprint

Focal Adhesion Protein-Tyrosine Kinases
Oncogene Proteins
Tyrosine
Phosphorylation
Cytochalasin D
Interleukin-3
Cell Line
Protein-Tyrosine Kinases
Intercellular Signaling Peptides and Proteins
Leukemia
Complementary DNA
Philadelphia Chromosome
Stem Cell Factor
Myeloid Cells
Neuropeptides
Actin Cytoskeleton
Cell Adhesion
Transfection
Phosphotransferases

Keywords

  • BCR-ABL
  • Focal adhesion kinase
  • Signal transduction
  • Tyrosine phosphorylation

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein. / Gotoh, A.; Miyazawa, K.; Ohyashiki, K.; Tauchi, T.; Boswell, H.; Broxmeyer, Hal; Toyama, K.

In: Experimental Hematology, Vol. 23, No. 11, 1995, p. 1153-1159.

Research output: Contribution to journalArticle

Gotoh, A, Miyazawa, K, Ohyashiki, K, Tauchi, T, Boswell, H, Broxmeyer, H & Toyama, K 1995, 'Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein', Experimental Hematology, vol. 23, no. 11, pp. 1153-1159.
Gotoh, A. ; Miyazawa, K. ; Ohyashiki, K. ; Tauchi, T. ; Boswell, H. ; Broxmeyer, Hal ; Toyama, K. / Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein. In: Experimental Hematology. 1995 ; Vol. 23, No. 11. pp. 1153-1159.
@article{7dd4f206cd134ad5abc28d0cb3ad5571,
title = "Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein",
abstract = "Focal adhesion kinase (p125(FAK); FAK) is a protein tyrosine kinase that is tyrosine-phosphorylated in response to v-src-mediated transformation cell adhesion, and stimulation with neuropeptides. To elucidate a possible functional relationship between FAK and BCR-ABL oncoprotein detected in Philadelphia chromosome-positive (Ph+) leukemias, we investigated the tyrosine phosphorylation state of FAK in a murine growth factor-dependent cell line and in its stable human bcr-abl cDNA transfectant. In interleukin-3 (IL-3)-dependent NFS/N1.H7 cells, tyrosine phosphorylation of FAK was not detected after stimulation with either IL-3 or Steel factor (SLF), both of which involve Pas-mediated signaling pathways. However, stable gene transfection with p210(bcr-abl) cDNA into H7 cells made these cells growth factor-independent for proliferation and resulted in constitutive tyrosine phosphorylation and kinase activation of FAK. Constitutive phosphorylation and activation of PAK was also observed in all Ph+ leukemia cell lines examined-that is, K562, TS9;22, and YS9;22, which express p210(BCR-ABL), and NALM-21 and YS9;22, which express p185(BCR-ABL). Ph-negative (Ph-) cell lines, such as MO7e and JM, did not show any detectable tyrosine phosphorylation of FAK. FAK phosphorylation in BCR-ABL-expressing cells was inhibited in a dose-dependent manner by cytochalasin D, a reagent that disrupts the intracellular network of actin filaments. However, no suppression of kinase activity or protein expression of BCR-ABL was observed after treatment with cytochalasin D. A physical association between BCR-ABL and FAK was not apparent. These data suggest that BCR-ABL may be involved in the activation of FAK. Moreover, FAK may be distinct from components in Pas-mediated signaling cascades that are activated by stimulation of myeloid cells with various cytokines.",
keywords = "BCR-ABL, Focal adhesion kinase, Signal transduction, Tyrosine phosphorylation",
author = "A. Gotoh and K. Miyazawa and K. Ohyashiki and T. Tauchi and H. Boswell and Hal Broxmeyer and K. Toyama",
year = "1995",
language = "English (US)",
volume = "23",
pages = "1153--1159",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Tyrosine phosphorylation and activation of focal adhesion kinase (p125(FAK)) by BCR-ABL oncoprotein

AU - Gotoh, A.

AU - Miyazawa, K.

AU - Ohyashiki, K.

AU - Tauchi, T.

AU - Boswell, H.

AU - Broxmeyer, Hal

AU - Toyama, K.

PY - 1995

Y1 - 1995

N2 - Focal adhesion kinase (p125(FAK); FAK) is a protein tyrosine kinase that is tyrosine-phosphorylated in response to v-src-mediated transformation cell adhesion, and stimulation with neuropeptides. To elucidate a possible functional relationship between FAK and BCR-ABL oncoprotein detected in Philadelphia chromosome-positive (Ph+) leukemias, we investigated the tyrosine phosphorylation state of FAK in a murine growth factor-dependent cell line and in its stable human bcr-abl cDNA transfectant. In interleukin-3 (IL-3)-dependent NFS/N1.H7 cells, tyrosine phosphorylation of FAK was not detected after stimulation with either IL-3 or Steel factor (SLF), both of which involve Pas-mediated signaling pathways. However, stable gene transfection with p210(bcr-abl) cDNA into H7 cells made these cells growth factor-independent for proliferation and resulted in constitutive tyrosine phosphorylation and kinase activation of FAK. Constitutive phosphorylation and activation of PAK was also observed in all Ph+ leukemia cell lines examined-that is, K562, TS9;22, and YS9;22, which express p210(BCR-ABL), and NALM-21 and YS9;22, which express p185(BCR-ABL). Ph-negative (Ph-) cell lines, such as MO7e and JM, did not show any detectable tyrosine phosphorylation of FAK. FAK phosphorylation in BCR-ABL-expressing cells was inhibited in a dose-dependent manner by cytochalasin D, a reagent that disrupts the intracellular network of actin filaments. However, no suppression of kinase activity or protein expression of BCR-ABL was observed after treatment with cytochalasin D. A physical association between BCR-ABL and FAK was not apparent. These data suggest that BCR-ABL may be involved in the activation of FAK. Moreover, FAK may be distinct from components in Pas-mediated signaling cascades that are activated by stimulation of myeloid cells with various cytokines.

AB - Focal adhesion kinase (p125(FAK); FAK) is a protein tyrosine kinase that is tyrosine-phosphorylated in response to v-src-mediated transformation cell adhesion, and stimulation with neuropeptides. To elucidate a possible functional relationship between FAK and BCR-ABL oncoprotein detected in Philadelphia chromosome-positive (Ph+) leukemias, we investigated the tyrosine phosphorylation state of FAK in a murine growth factor-dependent cell line and in its stable human bcr-abl cDNA transfectant. In interleukin-3 (IL-3)-dependent NFS/N1.H7 cells, tyrosine phosphorylation of FAK was not detected after stimulation with either IL-3 or Steel factor (SLF), both of which involve Pas-mediated signaling pathways. However, stable gene transfection with p210(bcr-abl) cDNA into H7 cells made these cells growth factor-independent for proliferation and resulted in constitutive tyrosine phosphorylation and kinase activation of FAK. Constitutive phosphorylation and activation of PAK was also observed in all Ph+ leukemia cell lines examined-that is, K562, TS9;22, and YS9;22, which express p210(BCR-ABL), and NALM-21 and YS9;22, which express p185(BCR-ABL). Ph-negative (Ph-) cell lines, such as MO7e and JM, did not show any detectable tyrosine phosphorylation of FAK. FAK phosphorylation in BCR-ABL-expressing cells was inhibited in a dose-dependent manner by cytochalasin D, a reagent that disrupts the intracellular network of actin filaments. However, no suppression of kinase activity or protein expression of BCR-ABL was observed after treatment with cytochalasin D. A physical association between BCR-ABL and FAK was not apparent. These data suggest that BCR-ABL may be involved in the activation of FAK. Moreover, FAK may be distinct from components in Pas-mediated signaling cascades that are activated by stimulation of myeloid cells with various cytokines.

KW - BCR-ABL

KW - Focal adhesion kinase

KW - Signal transduction

KW - Tyrosine phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=0028889810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028889810&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 1153

EP - 1159

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 11

ER -